<Suppliers Price>

Mps1-IN-2

Names

[ CAS No. ]:
1228817-38-6

[ Name ]:
Mps1-IN-2

[Synonym ]:
6H-Pyrimido[4,5-b][1,4]diazepin-6-one, 9-cyclopentyl-2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,7,8,9-tetrahydro-5-methyl-
9-Cyclopentyl-2-{[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino}-5-methyl-5,7,8,9-tetrahydro-6H-pyrimido[4,5-b][1,4]diazepin-6-one
Mps1-IN-2

Biological Activity

[Description]:

Mps1-IN-2 is a potent, selective and ATP-competitive dual Mps1/Plk1 inhibitor, with an IC50 and a Kd of 145 nM and 12 nM for Mps1 and a Kd of 61 nM for Plk1.

[Related Catalog]:

Signaling Pathways >> Cell Cycle/DNA Damage >> Mps1
Signaling Pathways >> Cytoskeleton >> Mps1
Signaling Pathways >> Cell Cycle/DNA Damage >> Polo-like Kinase (PLK)
Research Areas >> Cancer

[Target]

Mps1:12 nM (Kd)

GAK:140 nM (Kd)

PLK1:61 nM (Kd)

PLK3:1600 nM (Kd)

PLK4:3100 nM (Kd)

STK33:5000 nM (Kd)


[In Vitro]

Mps1-IN-2 is a potent, selective and ATP-competitive Mps1 kinase inhibitor, with an IC50 and a Kd of 145 nM and 12 nM. Mps1-IN-2 also shows high affinity for PLK1 and GAK with Kds of 61 and 140 nM, respectively, but shows little or no inhibition on other 352 member kinases. Mps1-IN-2 can induces bypass of a checkpoint-mediated mitotic arrest in U2OS cells[1].

[Kinase Assay]

The kinase binding assay is used to assess compound binding to TTK by monitoring displacement of a fluorescently labeled, ATP site-directed kinase inhibitor (Kinase Tracer 236) from the kinase active site. Each 15 μL assay contains 5 nM TTK, variable amounts of test compound (Mps1-IN-2), 30 nM Kinase Tracer 236, 2 nM Eu-anti-GST Antibody, and 1% DMSO (residual from compound dilution) in Kinase Buffer A (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.01% Brij-35). Binding assays are initiated by addition of 5 μL of test compound (from 2-fold dilution series) to 5 μL of a kinase/antibody mixture, followed by addition of 5 μL of antibody. Assay plates are read using using standard Eu-based TR-FRET settings with excitation at 340 nm and emission monitored at 615 nm (donor) and 665 nm (acceptor). Emission intensities are measured over a 200 µs window following a 100 µs post-excitation delay[1].

[References]

[1]. Kwiatkowski N, et al. Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat Chem Biol. 2010 May;6(5):359-68.


[Related Small Molecules]

Volasertib (BI 6727) | BI 2536 | Centrinone | CFI402257 | Rigosertib sodium | BAY1217389 | CFI-400945 | GSK461364 | GW843682X | TAK-960 | NMS-1286937 | BAY 1161909 | NMS-P715 | Poloxin | LFM-A13

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
772.7±70.0 °C at 760 mmHg

[ Molecular Formula ]:
C26H36N6O3

[ Molecular Weight ]:
480.602

[ Flash Point ]:
421.1±35.7 °C

[ Exact Mass ]:
480.284882

[ PSA ]:
94.06000

[ LogP ]:
2.05

[ Vapour Pressure ]:
0.0±2.8 mmHg at 25°C

[ Index of Refraction ]:
1.633

[ Storage condition ]:
2-8℃

Safety Information

[ RIDADR ]:
NONH for all modes of transport


Related Compounds